Advertisement

< Back to Article

Targeting Neuropilin-1 to Inhibit VEGF Signaling in Cancer: Comparison of Therapeutic Approaches

Figure 6

Average VEGF–VEGFR2 Signaling Inhibition over the 48 Hours Following Treatment

Endothelial cells expressing 10,000 VEGFR1, 10,000 VEGFR2, and 100,000 Neuropilin-1.

Figure 6

doi: https://doi.org/10.1371/journal.pcbi.0020180.g006